| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |